Conferences
2–6 December 2012, San Diego, CA, USA
IBC's Annual International Conference - Antibody Engineering and Antibody Therapeutics
IBC's Antibody Engineering and Antibody Therapeutics conferences are the world's leading forums for the exchange of cutting-edge protein engineering science. Now in its 23rd year, Antibody Engineering has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees come back year after year for the information they need to find new approaches to developing novel medicines and vaccines and to improve the safety and efficacy of antibody therapeutics now in development.
Topics:
Antibody Engineering
- Antibody Activity and Animal Models
- Antibody-Targeted CNS Therapy Beyond the Blood Brain Barrier
- Intellectual Property Issues Impacting Antibody Engineering
- Deep Sequencing in B Cell Biology and Antibody Libraries
- New Targets for Antibody-Based Cancer Therapy
- Systematic Validation of Novel Antibody Targets
- Systems Medicine in the Future of Immunotherapy
Antibody Therapeutics
- Antibodies in Clinical Development
- Clinical Updates of Antibody Drug Conjugates
- Development Status of Early Stage Therapeutic Antibodies
